ArticleACS medicinal chemistry letters2025
Identification of Indazole- and Azaindazole-Substituted Cyclopentapyrroles as G2019S Leucine-Rich Repeat Kinase 2 Inhibitors for the Treatment of CNS Disorders.
Siyan Feng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.